Detalhe da pesquisa
1.
Mutational processes molding the genomes of 21 breast cancers.
Cell;
149(5): 979-93, 2012 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22608084
2.
A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.
Gastroenterology;
166(5): 872-885.e2, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38320723
3.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med;
384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34081848
4.
Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions.
Ann Surg Oncol;
31(5): 3120-3127, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38261128
5.
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
Oncologist;
28(7): 565-574, 2023 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37210568
6.
A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome.
Genome Res;
30(8): 1170-1180, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32817165
7.
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Breast Cancer Res Treat;
200(1): 63-72, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36856935
8.
Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis.
Ann Surg Oncol;
30(1): 68-77, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36171529
9.
The clinical and functional effects of TERT variants in myelodysplastic syndrome.
Blood;
138(10): 898-911, 2021 09 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34019641
10.
Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers.
J Genet Couns;
32(2): 342-350, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36245263
11.
Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
Cancer;
128(6): 1275-1283, 2022 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34875721
12.
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer.
Br J Cancer;
126(2): 302-309, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34703009
13.
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen.
Breast Cancer Res Treat;
193(2): 417-427, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35378642
14.
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study.
Genet Med;
24(3): 564-575, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34906490
15.
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study.
J Gen Intern Med;
37(8): 1862-1869, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34173196
16.
Impact of Genetic Counseling on Patient-Reported Electronic Cancer Family History Collection.
J Natl Compr Canc Netw;
20(8): 898-905.e2, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35948032
17.
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
Breast Cancer Res Treat;
189(3): 641-651, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34417675
18.
Histopathologic features of breast cancer in Li-Fraumeni syndrome.
Mod Pathol;
34(3): 542-548, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32636452
19.
Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Gynecol Oncol;
160(2): 457-463, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33229043
20.
Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines.
Hum Mutat;
41(9): 1555-1562, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32485079